Found: 2934
Select item for more details and to access through your institution.
Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling.
- Published in:
- Clinical Pharmacokinetics, 2024, v. 63, n. 10, p. 1449, doi. 10.1007/s40262-024-01425-9
- By:
- Publication type:
- Article
Terapia biológica en cáncer: nuevos tiempos con una visión optimista.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Chronic Phase Chronic Myeloid Leukemia: More Drugs, More Lives Saved, New Challenges.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
Optimal First-Line Treatment of Chronic Myeloid Leukemia: How to Use Imatinib and What Role for Newer Drugs?
- Published in:
- Oncology (08909091), 2007, v. 21, n. 6, p. 653
- By:
- Publication type:
- Article
The Unfolding Story of Imatinib Mesylate for Chronic Myeloid Leukemia.
- Published in:
- 2007
- By:
- Publication type:
- Editorial
New Options to Treat Chronic Myeloid Leukemia, Overcome Imatinib Resistance.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 1, p. 110
- Publication type:
- Article
Imatinib Sets New Treatment Standard in Patients With Chronic Myeloid Leukemia.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 8, p. 935
- Publication type:
- Article
The Savona/Talpaz Article Reviewed.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 7, p. 719
- By:
- Publication type:
- Article
Current Strategies in the Management of Lung Cancer.
- Published in:
- Oncology (08909091), 2005, v. 19, n. 13, p. 1667
- By:
- Publication type:
- Article
SU11248 Shows Early Efficacy and Safety in Imatinib-Resistant GI Stromal Tumors.
- Published in:
- 2005
- Publication type:
- Report
The efficacy of generic imatinib in patients with chronic myeloid leukemia - a single center experience.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2021, v. 78, n. 5, p. 526, doi. 10.2298/VSP190620095U
- By:
- Publication type:
- Article
Erdheim-Chester disease -A case report.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Malignant stromal tumor of the stomach with giant cystic liver metastases prior to treatment with imatinib mesylate.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2013, v. 70, n. 2, p. 225, doi. 10.2298/VSP1302225C
- By:
- Publication type:
- Article
Faktori koji utiču na postizanje i postojanost citogenetskog odgovora kod bolesnika sa hroničnom mijeloidnom leukemijom na terapiji imatinibom.
- Published in:
- Vojnosanitetski Pregled: Military Medical & Pharmaceutical Journal of Serbia, 2011, v. 68, n. 11, p. 911, doi. 10.2298/VSP1111911C
- By:
- Publication type:
- Article
Successful Progressive Challenge after a Cutaneous Reaction to Imatinib Mesylate (Gleevec): A Case Report and Review of the Literature.
- Published in:
- Allergy & Asthma Proceedings, 2004, v. 25, n. 5, p. 345
- By:
- Publication type:
- Article
A new case of imatinib-induced drug reaction with eosinophilia and systemic symptoms.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Imatinib mesylate-induced pseudoporphyria in a patient with chronic myeloid leukemia.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Imatinib induced melasma-like pigmentation: Report of five cases and review of literature.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Imatinib mesylate induced erythroderma.
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Imatinib induced Stevens-Johnson syndrome: lack of recurrence following re-challenge with a lower dose.
- Published in:
- 2005
- By:
- Publication type:
- Case Study
Lichenoid eruption due to imatinib.
- Published in:
- 2005
- By:
- Publication type:
- Case Study
Generalized hypopigmentation due to imatinib: a fairness boon?
- Published in:
- 2005
- By:
- Publication type:
- research
Cardiotoxicity in Hematological Diseases: Are the Tyrosine Kinase Inhibitors Imatinib and Nilotinib Safe?
- Published in:
- Cardiovascular Toxicology, 2018, v. 18, n. 5, p. 431, doi. 10.1007/s12012-018-9453-3
- By:
- Publication type:
- Article
Determination of sulfonate ester genotoxic impurities in imatinib mesylate by gas chromatography with mass spectrometry.
- Published in:
- Journal of Separation Science, 2016, v. 39, n. 18, p. 3558, doi. 10.1002/jssc.201600389
- By:
- Publication type:
- Article
Pluronic F127 as a suitable carrier for preparing the imatinib base solid dispersions and its potential in development of a modified release dosage forms.
- Published in:
- Journal of Thermal Analysis & Calorimetry, 2017, v. 130, n. 1, p. 383, doi. 10.1007/s10973-017-6139-1
- By:
- Publication type:
- Article
A novel polyamidoamine dendrimer based nano-carrier for oral delivery of imatinib.
- Published in:
- Journal of Polymer Research, 2022, v. 29, n. 12, p. 1, doi. 10.1007/s10965-022-03359-x
- By:
- Publication type:
- Article
Magnetite graphene oxide-albumin conjugate: carrier for the imatinib anticancer drug.
- Published in:
- Journal of Materials Science: Materials in Medicine, 2023, v. 34, n. 7, p. 1, doi. 10.1007/s10856-023-06735-1
- By:
- Publication type:
- Article
Global identification of circular RNAs in imatinib (IM) resistance of chronic myeloid leukemia (CML) by modulating signaling pathways of circ_0080145/miR-203/ABL1 and circ 0051886/miR-637/ABL1.
- Published in:
- Molecular Medicine, 2021, v. 27, n. 1, p. 1, doi. 10.1186/s10020-021-00395-z
- By:
- Publication type:
- Article
Apoptotic profiling of chronic myeloid leukaemia patients' platelets ex vivo before and after treatment with Imatinib.
- Published in:
- Cell Biochemistry & Function, 2021, v. 39, n. 4, p. 562, doi. 10.1002/cbf.3625
- By:
- Publication type:
- Article
Effects of Chemotherapy during Pregnancy on the Placenta.
- Published in:
- Pediatric & Developmental Pathology, 2009, v. 12, n. 1, p. 35, doi. 10.2350/08-03-0435.1
- By:
- Publication type:
- Article
Imatinib Mesylate Does Not Increase Bone Volume In Vivo.
- Published in:
- Calcified Tissue International, 2011, v. 88, n. 1, p. 16, doi. 10.1007/s00223-010-9429-1
- By:
- Publication type:
- Article
Delayed adjuvant imatinib in patients with high risk of recurrence of gastrointestinal stromal tumor after radical surgery: a retrospective cohort study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 6, p. 1493, doi. 10.1007/s00432-021-03749-6
- By:
- Publication type:
- Article
Patient-reported outcomes in the phase 3 BFORE trial of bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2019, v. 145, n. 6, p. 1589, doi. 10.1007/s00432-019-02894-3
- By:
- Publication type:
- Article
Systematic review and meta-analysis of standard-dose imatinib vs. high-dose imatinib and second generation tyrosine kinase inhibitors for chronic myeloid leukemia.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 7, p. 1311, doi. 10.1007/s00432-017-2385-7
- By:
- Publication type:
- Article
No influence of BCR-ABL1 transcript types e13a2 and e14a2 on long-term survival: results in 1494 patients with chronic myeloid leukemia treated with imatinib.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 5, p. 843, doi. 10.1007/s00432-016-2321-2
- By:
- Publication type:
- Article
Is 3-years duration of adjuvant imatinib mesylate treatment sufficient for patients with high-risk gastrointestinal stromal tumor? A study based on long-term follow-up.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2017, v. 143, n. 4, p. 727, doi. 10.1007/s00432-016-2334-x
- By:
- Publication type:
- Article
The development of dasatinib as a treatment for chronic myeloid leukemia (CML): from initial studies to application in newly diagnosed patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2013, v. 139, n. 12, p. 1971, doi. 10.1007/s00432-013-1488-z
- By:
- Publication type:
- Article
Enhanced ABL-inhibitor-induced MAPK-activation in T315I-BCR-ABL-expressing cells: a potential mechanism of altered leukemogenicity.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2012, v. 138, n. 2, p. 203, doi. 10.1007/s00432-011-1086-x
- By:
- Publication type:
- Article
Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2011, v. 137, n. 10, p. 1535, doi. 10.1007/s00432-011-1016-y
- By:
- Publication type:
- Article
Novel treatment of ovarian cancer cell lines with Imatinib mesylate combined with Paclitaxel and Carboplatin leads to receptor-mediated antiproliferative effects.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2008, v. 134, n. 12, p. 1397, doi. 10.1007/s00432-008-0408-0
- By:
- Publication type:
- Article
Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs).
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2007, v. 133, n. 9, p. 589, doi. 10.1007/s00432-007-0202-4
- By:
- Publication type:
- Article
Control of aggressive fibromatosis by treatment with imatinib mesylate. A case report and review of the literature.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2007, v. 133, n. 8, p. 533, doi. 10.1007/s00432-007-0198-9
- By:
- Publication type:
- Article
Follow-up of gastro-intestinal stromal tumours (GIST) during treatment with imatinib mesylate by abdominal MRI.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers.
- Published in:
- 2017
- By:
- Publication type:
- Letter
c-kit/CD 117 positive cells in the myometrium of pregnant women and those with uterine endometriosis.
- Published in:
- Archives of Gynecology & Obstetrics, 2012, v. 286, n. 1, p. 105, doi. 10.1007/s00404-012-2220-y
- By:
- Publication type:
- Article
Desmoid tumors of the right rectus abdominus muscle in postpartum women.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Pregnancy complicated with chronic myelogeneous leukemia (CML) successfully treated with imatinib: a case report.
- Published in:
- Archives of Gynecology & Obstetrics, 2008, v. 278, n. 2, p. 161, doi. 10.1007/s00404-007-0547-6
- By:
- Publication type:
- Article
Current Therapies for Chronic Myeloid Leukemia.
- Published in:
- Journal of Pharmacy Practice, 2008, v. 21, n. 2, p. 116, doi. 10.1177/0897190008314778
- By:
- Publication type:
- Article
A Newborn with Teratogenic Effect of Imatinib Mesylate: A Very Rare Case Report.
- Published in:
- Medical Principles & Practice, 2015, v. 24, n. 3, p. 291, doi. 10.1159/000381806
- By:
- Publication type:
- Article
Does Imatinib Mesylate Therapy Cause Growth Hormone Deficiency?
- Published in:
- Medical Principles & Practice, 2009, v. 18, n. 5, p. 360, doi. 10.1159/000226288
- By:
- Publication type:
- Article